{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:46:53Z","timestamp":1784180813145,"version":"3.55.0"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1053\/j.seminhematol.2007.11.004","type":"journal-article","created":{"date-parts":[[2007,12,20]],"date-time":"2007-12-20T15:52:14Z","timestamp":1198165934000},"page":"S24-S34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"S5","title":["Other Immune Thrombocytopenias"],"prefix":"10.1053","volume":"44","author":[{"given":"Howard","family":"Liebman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2007.11.004_bib1","series-title":"Hematology: Basic Principles and Practice","article-title":"Immune thrombocytopenic purpura, neonatal alloimmune thrombocytopenia, and post-transfusion purpura","author":"Bussel","year":"2005"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib2","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib3","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(05)60004-9","article-title":"Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori","volume":"352","author":"Gasbarrini","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2257.1985.tb00002.x","article-title":"The relative incidence of idiopathic and secondary autoimmune thrombocytopenia: a clinical and serological evaluation in 508 patients","volume":"7","author":"Hedge","year":"1985","journal-title":"Clin Lab Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1600-0609.1982.tb00533.x","article-title":"Primary and secondary autoimmune thrombocytopenia","volume":"28","author":"Helmerhorst","year":"1982","journal-title":"Scand J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib6","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1182\/blood.V63.4.944.944","article-title":"Platelet-associated IgG in patients with lymphoma","volume":"63","author":"Berkman","year":"1984","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1600-0609.1992.tb00913.x","article-title":"Mechanisms of thrombocytopenia in patients with lymphoproliferative diseases","volume":"49","author":"Kuznetsov","year":"1992","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0002-9343(81)90243-6","article-title":"Peripheral destruction of platelets in chronic lymphocytic leukemia: Recognition, prognosis and therapeutic implications","volume":"71","author":"Rubinstein","year":"1981","journal-title":"Am J Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","article-title":"A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis","volume":"48","author":"Binet","year":"1981","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/10428199409051678","article-title":"Autoimmune thrombocytopenic purpura complicating lymphoproliferative disorders","volume":"15","author":"Lim","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib12","first-page":"235","article-title":"Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: Analysis of 637 cases and comparison with myeloproliferative diseases","volume":"67","author":"Duhrsen","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib13","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/jcp.39.7.713","article-title":"Autoimmunity in chronic lymphocytic leukaemia","volume":"39","author":"Hamblin","year":"1986","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1600-0609.1988.tb00853.x","article-title":"Idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia in Hodgkin\u2019s disease","volume":"40","author":"Xiros","year":"1988","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00000441-198007000-00004","article-title":"Idiopathic thrombocytopenic purpura and Hodgkin\u2019s disease: Report of two cases and a review of the literature","volume":"280","author":"Kirshner","year":"1980","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib16","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/1097-0142(197604)37:4<1999::AID-CNCR2820370451>3.0.CO;2-U","article-title":"Idiopathic thrombocytopenic purpura in lymphoma","volume":"37","author":"Fink","year":"1976","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1600-0609.1986.tb01758.x","article-title":"Thrombocytopenic purpura as first manifestation of an inapparent Hodgkin\u2019s disease","volume":"36","author":"Pedro-Botet","year":"1986","journal-title":"Scand J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/1097-0142(197802)41:2<743::AID-CNCR2820410247>3.0.CO;2-F","article-title":"Idiopathic thrombocytopenic purpura in Hodgkin\u2019s disease: A rare occurrence of no prognostic significance","volume":"41","author":"Cohen","year":"1978","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib19","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/1097-0142(197305)31:5<1092::AID-CNCR2820310509>3.0.CO;2-B","article-title":"Autoimmune disorders and malignant lymphoma","volume":"31","author":"Jones","year":"1973","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib20","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1002\/1097-0142(19871101)60:9<2308::AID-CNCR2820600932>3.0.CO;2-I","article-title":"Primary hepatic lymphoma presenting as symptomatic immune thrombocytopenic purpura","volume":"60","author":"Aghai","year":"1987","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0002-9343(79)90781-2","article-title":"A syndrome resembling idiopathic thrombocytopenic purpura in 10 patients with diverse forms of cancer","volume":"67","author":"Kim","year":"1979","journal-title":"Am J Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1056\/NEJM198701223160406","article-title":"Complement-mediated autoimmune thrombocytopenia","volume":"316","author":"Lehman","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib23","first-page":"605","article-title":"Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus","volume":"80","author":"Nossent","year":"1991","journal-title":"Q J Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(91)90057-7","article-title":"Lupus erythematosus in the 1980s: A survey of 570 patients","volume":"21","author":"Pistiner","year":"1991","journal-title":"Semin Arthritis Rheum"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib25","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/SMJ.0b013e318046583f","article-title":"Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus","volume":"100","author":"George","year":"2007","journal-title":"South Med J"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib26","first-page":"858","article-title":"Thrombotic thrombocytopenic purpura (TTP) and systemic lupus erythematosus (SLE): Distinct but potentially overlapping syndromes","volume":"104","author":"Hunt","year":"2004","journal-title":"ASH Annual Meeting Abstracts"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1078\/0171-2985-00213","article-title":"Clinical and epidemiological aspects in the antiphospholipid syndrome","volume":"207","author":"Cervera","year":"2003","journal-title":"Immunobiology"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib28","first-page":"355","article-title":"Rituximab treatment for resistant antiphospholipid syndrome","volume":"33","author":"Rubenstein","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V88.1.3.3","article-title":"Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology","volume":"88","author":"George","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000207396","article-title":"Thrombocytopenia in Graves\u2019 disease: Effect of T3 on platelet kinetics","volume":"63","author":"Kurata","year":"1980","journal-title":"Acta Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.7326\/0003-4819-67-2-411","article-title":"Coexistent idiopathic thrombocytopenic purpura and hyperthyroidism","volume":"67","author":"Marshall","year":"1967","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib32","first-page":"469","article-title":"Association between thyrotoxicosis and thrombocytopenia","volume":"14","author":"Herman","year":"1978","journal-title":"Isr J Med Sci"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib33","series-title":"The Thyroid and Its Diseases","author":"DeGroot","year":"1996"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib34","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","article-title":"Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature","volume":"101","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1600-0609.1996.tb01934.x","article-title":"Prevalence of antibodies to cardiolipin in chronic ITP and reactivity with platelet membranes","volume":"56","author":"Arfors","year":"1996","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib37","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2141.2004.05314.x","article-title":"Antiphospholipid antibodies in immune thrombocytopenic purpura tend to emerge in exacerbation and decline in remission","volume":"128","author":"Bidot","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/ajh.20571","article-title":"Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS)","volume":"81","author":"Bidot","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib39","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1182\/blood.V98.6.1760","article-title":"Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: A prospective cohort study","volume":"98","author":"Diz-Kucukkaya","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib40","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1600-0609.1998.tb01041.x","article-title":"Antibodies against platelet glycoproteins and antiphospholipid antibodies in autoimmune thrombocytopenia","volume":"60","author":"Lipp","year":"1998","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib41","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1182\/blood.V84.12.4203.bloodjournal84124203","article-title":"Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura","volume":"84","author":"Stasi","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib42","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/BF02724290","article-title":"Lupus anticoagulant in immune thrombocytopenic purpura","volume":"71","author":"Dash","year":"2004","journal-title":"Indian J Pediatr"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib43","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1046\/j.1365-2141.2002.03729.x","article-title":"Detection of lupus anticoagulant identifies patients with autoimmune haemolytic anaemia at increased risk for venous thromboembolism","volume":"118","author":"Pullarkat","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib44","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1111\/j.1538-7836.2005.01485.x","article-title":"Lupus anticoagulants and the risk of a first episode of deep venous thrombosis","volume":"3","author":"de Groot","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib45","doi-asserted-by":"crossref","first-page":"714","DOI":"10.7326\/0003-4819-96-6-714","article-title":"Autoimmune thrombocytopenic purpura in homosexual men","volume":"96","author":"Morris","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib46","doi-asserted-by":"crossref","first-page":"474","DOI":"10.7326\/0003-4819-107-4-474","article-title":"Infection with the human immunodeficiency virus: Clinical manifestations and their relationship to immune deficiency","volume":"107","author":"Kaslow","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib47","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2141.1992.tb06476.x","article-title":"Prevalence of thrombocytopenia in HIV-infected and non-HIV infected drug users and homosexual men","volume":"82","author":"Mientjes","year":"1992","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-2141.1987.tb06920.x","article-title":"Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection","volume":"66","author":"Murphy","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib49","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00002030-199104000-00004","article-title":"Frequency and prognostic importance of thrombocytopenia in symptom-free HIV-infected individuals: A 5-year prospective study","volume":"5","author":"Peltier","year":"1991","journal-title":"Aids"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib50","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/aid.1990.6.261","article-title":"Prevalence, clinical, and laboratory features of thrombocytopenia among HIV-infected individuals","volume":"6","author":"Rossi","year":"1990","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib51","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-0609.1992.tb00591.x","article-title":"Epidemiology of thrombocytopenia in HIV infection","volume":"48","author":"Sloand","year":"1992","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib52","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00042560-199704010-00011","article-title":"Surveillance for thrombocytopenia in persons infected with HIV: Results from the multistate Adult and Adolescent Spectrum of Disease Project","volume":"14","author":"Sullivan","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib53","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/01.qai.0000134759.01684.27","article-title":"Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women\u2019s Interagency HIV Study","volume":"37","author":"Berhane","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib54","first-page":"405","article-title":"Neutropenia in human immunodeficiency virus infection: data from the women\u2019s interagency HIV study","volume":"166","author":"Levine","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib55","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1600-0609.1990.tb00422.x","article-title":"Low incidence of bleeding from HIV-related thrombocytopenia in drug addicts and hemophiliacs: Implications for therapeutic strategies","volume":"45","author":"Finazzi","year":"1990","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib56","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1182\/blood.V75.6.1267.1267","article-title":"Hemorrhagic sequelae of immune thrombocytopenic purpura in human immunodeficiency virus-infected hemophiliacs","volume":"75","author":"Ragni","year":"1990","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib57","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1136\/bmj.323.7318.920","article-title":"ABC of the upper gastrointestinal tract: Epidemiology and diagnosis of Helicobacter pylori infection","volume":"323","author":"Logan","year":"2001","journal-title":"BMJ"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib58","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","article-title":"Helicobacter pylori infection","volume":"347","author":"Suerbaum","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib59","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF02983780","article-title":"Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura?","volume":"77","author":"Ando","year":"2003","journal-title":"Int J Hematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib60","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/09537100400028685","article-title":"Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura: Correlation with Helicobacter pylori infection and response to eradication treatment","volume":"16","author":"Veneri","year":"2005","journal-title":"Platelets"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib61","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1083-4389.2004.00261.x","article-title":"Characteristics of Helicobacter pylori-induced gastritis and the effect of H. pylori eradication in patients with chronic idiopathic thrombocytopenic purpura","volume":"9","author":"Ando","year":"2004","journal-title":"Helicobacter"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib62","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood.V97.3.812","article-title":"Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura","volume":"97","author":"Emilia","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib63","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1532\/IJH97.04146","article-title":"Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura?","volume":"81","author":"Fujimura","year":"2005","journal-title":"Int J Hematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib64","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/BF02983220","article-title":"Platelet recovery in patients with idiopathic thrombocytopenic purpura after eradication of Helicobacter pylori","volume":"77","author":"Hashino","year":"2003","journal-title":"Int J Hematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib65","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00277-002-0579-8","article-title":"Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura","volume":"82","author":"Hino","year":"2003","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib66","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2362.2005.01471.x","article-title":"Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan","volume":"35","author":"Inaba","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib67","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1046\/j.1365-2141.2001.03194.x","article-title":"Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura","volume":"115","author":"Jarque","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib68","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1046\/j.1365-2141.2002.03612.x","article-title":"Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura","volume":"118","author":"Kohda","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib69","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1182\/blood-2003-03-0900","article-title":"Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura?","volume":"103","author":"Michel","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib70","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1600-0609.2004.00220.x","article-title":"The effects of Helicobacter pylori eradication on chemokine production in patients with immune thrombocytopenic purpura","volume":"72","author":"Nomura","year":"2004","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib71","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1001\/archinte.164.17.1904","article-title":"Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura","volume":"164","author":"Sato","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib72","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.amjmed.2004.09.014","article-title":"Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura","volume":"118","author":"Stasi","year":"2005","journal-title":"Am J Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib73","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/09537100500462487","article-title":"Helicobacter pylori eradication can induce platelet recovery in chronic idiopathic thrombocytopenic purpura","volume":"17","author":"Suvajdzic","year":"2006","journal-title":"Platelets"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib74","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1572-0241.2005.41641.x","article-title":"Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura\u2014A randomized controlled trial","volume":"100","author":"Suzuki","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib75","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2141.2003.04735.x","article-title":"Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura","volume":"124","author":"Takahashi","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib76","first-page":"1177","article-title":"Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura","volume":"87","author":"Veneri","year":"2002","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib77","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1182\/blood-2002-10-3201","article-title":"Helicobacter pylori and idiopathic thrombocytopenic purpura in children","volume":"101","author":"Rajantie","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib78","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/ajh.20302","article-title":"Autoimmune thrombocytopenic purpura and Helicobacter pylori infection effectivity during childhood","volume":"78","author":"Yetgin","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib79","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1046\/j.1365-2141.2000.02132.x","article-title":"HCV-associated thrombocytopenia: Clinical characteristics and platelet response after recombinant alpha2b-interferon therapy","volume":"110","author":"Garcia-Suarez","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib80","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0168-8278(95)80027-1","article-title":"Hepatitis C virus infection and autoimmune thrombocytopenic purpura","volume":"23","author":"Pawlotsky","year":"1995","journal-title":"J Hepatol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib81","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2141.1996.7542376.x","article-title":"High prevalence of autoimmune phenomena in hepatitis C virus antibody positive patients with lymphoproliferative and connective tissue disorders","volume":"95","author":"Pivetti","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib82","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1365-2141.2005.05542.x","article-title":"Hepatitis C virus-related thrombocytopenia: Clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura","volume":"129","author":"Rajan","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib83","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1034\/j.1600-0609.2002.00509.x","article-title":"Steroid-refractory chronic idiopathic thrombocytopenic purpura associated with hepatitis C virus infection","volume":"68","author":"Sakuraya","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib84","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1034\/j.1600-0609.2003.00032.x","article-title":"Hepatitis C virus-related adult chronic idiopathic thrombocytopenic purpura: Experience from a single Chinese center","volume":"70","author":"Zhang","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib85","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1111\/j.1572-0241.2002.05845.x","article-title":"Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection","volume":"97","author":"Pockros","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib86","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0037-1963(00)90103-3","article-title":"Advances in the diagnosis of idiopathic thrombocytopenic purpura","volume":"37","author":"Chong","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib87","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0037-1963(00)90102-1","article-title":"Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura","volume":"37","author":"McMillan","year":"2000","journal-title":"Semin Hematol"},{"issue":"suppl 1","key":"10.1053\/j.seminhematol.2007.11.004_bib88","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0037-1963(00)90111-2","article-title":"The pathogenesis of chronic immune (idiopathic) thrombocytopenic purpura","volume":"37","author":"McMillan","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib89","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood.V83.4.1024.1024","article-title":"Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura","volume":"83","author":"He","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib90","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood.V81.5.1255.1255","article-title":"Beta 2-glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets: differences with lupus anticoagulants","volume":"81","author":"Shi","year":"1993","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib91","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1055\/s-0037-1614491","article-title":"Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus\u2014Possible association with thrombotic and thrombocytopenic complications","volume":"81","author":"Nojima","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib92","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM198409063111004","article-title":"On the mechanism of thrombocytopenic purpura in sexually active homosexual men","volume":"311","author":"Walsh","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib93","doi-asserted-by":"crossref","first-page":"9763","DOI":"10.1073\/pnas.85.24.9763","article-title":"Anti-human immunodeficiency virus type 1 antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addicts","volume":"85","author":"Karpatkin","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib94","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1172\/JCI115593","article-title":"Autoimmune anti-HIV-1gp120 antibody with antiidiotype-like activity in sera and immune complexes of HIV-1-related immunologic thrombocytopenia","volume":"89","author":"Karpatkin","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib95","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1073\/pnas.92.6.2263","article-title":"Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor immune complexes of human immunodeficiency virus 1 thrombocytopenic patients","volume":"92","author":"Karpatkin","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib96","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1046\/j.1365-2141.1999.01469.x","article-title":"Differentiation of autoimmune thrombocytopenia from thrombocytopenia associated with immune complex disease: Systemic lupus erythematosus, hepatitis-cirrhosis, and HIV-1 infection by platelet and serum immunological measurements","volume":"105","author":"Samuel","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib97","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2141.1989.tb00259.x","article-title":"Immunochemical analysis of platelet autoantibodies in HIV-related thrombocytopenic purpura: A study of 68 patients","volume":"73","author":"Bettaieb","year":"1989","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib98","doi-asserted-by":"crossref","first-page":"7589","DOI":"10.1073\/pnas.94.14.7589","article-title":"GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia","volume":"94","author":"Nardi","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib99","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/blood.V80.1.162.162","article-title":"Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura","volume":"80","author":"Bettaieb","year":"1992","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib100","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/0140-6736(93)92363-X","article-title":"Common epitope on HIV p24 and human platelets","volume":"342","author":"Hohmann","year":"1993","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib101","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0092-8674(01)00477-9","article-title":"Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia","volume":"106","author":"Nardi","year":"2001","journal-title":"Cell"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib102","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJM199212173272503","article-title":"Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection","volume":"327","author":"Ballem","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib103","first-page":"1295","article-title":"Structural changes in the megakaryocytes of patients infected with the human immune deficiency virus (HIV-1)","volume":"134","author":"Zucker-Franklin","year":"1989","journal-title":"Am J Pathol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib104","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/10428190009148861","article-title":"HIV infection of megakaryocytic cell lines","volume":"36","author":"Sato","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2174\/157016206775197646","article-title":"Thrombocytopenia in HIV infection: impairment of platelet formation and loss correlates with increased c-Mpl and ligand thrombopoietin expression","volume":"4","author":"Sundell","year":"2006","journal-title":"Curr HIV Res"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib106","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1182\/blood-2005-01-0243","article-title":"Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia","volume":"106","author":"Li","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib107","doi-asserted-by":"crossref","first-page":"766","DOI":"10.7326\/0003-4819-140-9-200405040-00028","article-title":"Helicobacter pylori and idiopathic thrombocytopenic purpura","volume":"140","author":"Franceschi","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib108","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1440-1746.1994.tb01223.x","article-title":"Type C chronic hepatitis associated with thrombocytopenia in two patients","volume":"9","author":"Yabu","year":"1994","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib109","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1046\/j.1365-2141.2001.02824.x","article-title":"Hepatic fibrosis plays a central role in the pathogenesis of thrombocytopenia in patients with chronic viral hepatitis","volume":"113","author":"Adinolfi","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib110","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1182\/blood.V98.8.2293","article-title":"The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines","volume":"98","author":"Hamaia","year":"2001","journal-title":"Blood"},{"issue":"suppl 13","key":"10.1053\/j.seminhematol.2007.11.004_bib111","first-page":"S39","article-title":"A laboratory and thrombokinetic study of HCV-associated thrombocytopenia: A direct role of HCV in bone marrow exhaustion?","volume":"13","author":"Bordin","year":"1995","journal-title":"Clin Exp Rheumatol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib112","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1111\/j.1572-0241.2002.05845.x","article-title":"Immune thrombocytopenic purpura in patients with chronic hepatitis C virus infection","volume":"97","author":"Pockros","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib113","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(96)80021-3","article-title":"Thrombocytopenia associated with hepatitis C viral infection","volume":"24","author":"Nagamine","year":"1996","journal-title":"J Hepatol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib114","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archinte.1976.03630010046008","article-title":"Idiopathic thrombocytopenic purpura complicating chronic lymphocytic leukemia","volume":"136","author":"Carey","year":"1976","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib115","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1182\/blood.V53.4.545.545","article-title":"Immune thrombocytopenia in lymphoproliferative diseases","volume":"53","author":"Kaden","year":"1979","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib116","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1182\/blood.V100.6.2260","article-title":"Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia","volume":"100","author":"Hegde","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib117","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1038\/sj.leu.2402676","article-title":"Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia","volume":"16","author":"Gupta","year":"2002","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib118","first-page":"75","article-title":"Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases","volume":"29","author":"Arnal","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib119","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/archinte.1982.00340210052013","article-title":"Variable presentation of thrombocytopenia in Graves\u2019 disease","volume":"142","author":"Adrouny","year":"1982","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib120","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archinte.1997.00440300155015","article-title":"Graves disease associated with autoimmune thrombocytopenic purpura","volume":"157","author":"Hofbauer","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib121","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-0609.2004.00341.x","article-title":"Improvement of idiopathic thrombocytopenic purpura by antithyroid therapy","volume":"74","author":"Sugimoto","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib122","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/jcp.2004.016543","article-title":"Resolution of chronic severe refractory thrombocytopenia after treatment of hypothyroidism","volume":"57","author":"Bowles","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib123","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V98.4.952","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura","volume":"98","author":"Stasi","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib124","first-page":"ECR34","article-title":"Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome","volume":"89","author":"Erdozain","year":"2004","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib125","doi-asserted-by":"crossref","first-page":"542","DOI":"10.7326\/0003-4819-103-4-542","article-title":"Thrombocytopenia in homosexual patients","volume":"103","author":"Walsh","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib126","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1182\/blood.V89.8.2689","article-title":"Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients","volume":"89","author":"Scaradavou","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib127","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2141.1987.tb01333.x","article-title":"Response to therapy in 37 patients with HIV-related thrombocytopenic purpura","volume":"66","author":"Oksenhendler","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib128","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00002030-199001000-00004","article-title":"HIV-related severe thrombocytopenia in intravenous drug users: prevalence, response to therapy in a medium-term follow-up, and pathogenetic evaluation","volume":"4","author":"Landonio","year":"1990","journal-title":"Aids"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib129","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00042560-200111010-00003","article-title":"HIV-associated hematologic disorders are correlated with plasma viral load and improve under highly active antiretroviral therapy","volume":"28","author":"Servais","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00002030-199302000-00008","article-title":"Comparison of two dose regimens of zidovudine in an open, randomized, multicentre study for severe HIV-related thrombocytopenia","volume":"7","author":"Landonio","year":"1993","journal-title":"Aids"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib131","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/09537100120093956","article-title":"Thrombocytopenia in HIV-infected drug users in the HAART era","volume":"12","author":"Burbano","year":"2001","journal-title":"Platelets"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib132","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00042560-200206010-00017","article-title":"Limited impact of highly active antiretroviral therapy in thrombocytopenia","volume":"30","author":"Miguez","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib133","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1572-0241.2005.41641.x","article-title":"Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura: A randomized controlled trial","volume":"100","author":"Suzuki","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib134","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/09537100400015153","article-title":"High prevalence of sustained remission of idiopathic thrombocytopenic purpura after Helicobacter pylori eradication: A long-term follow-up study","volume":"16","author":"Veneri","year":"2005","journal-title":"Platelets"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib135","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1053\/j.seminhematol.2007.11.004_bib136","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.1002\/hep.1840360730","article-title":"Side effects of therapy of hepatitis C and their management","volume":"36","author":"Fried","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib137","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib138","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000040842","article-title":"Autoimmune thrombocytopenia associated with hepatitis C virus infection","volume":"99","author":"Hernandez","year":"1998","journal-title":"Acta Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib139","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00005792-200303000-00003","article-title":"Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: Clinical description of 35 cases","volume":"82","author":"Ramos-Casals","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib140","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1046\/j.1365-2141.2000.02132.x","article-title":"HCV-associated thrombocytopenia: clinical characteristics and platelet response after recombinant \u03b12b-interferon therapy","volume":"110","author":"Garcia-Suarez","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib141","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1600-0609.2005.00524.x","article-title":"Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon-\u03b1B1; therapy: Possible etiology of HCV-associated immune thrombocytopenia","volume":"75","author":"Iga","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib142","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ajh.1180","article-title":"Treatment of hepatitis C related thrombocytopenia with interferon alpha","volume":"68","author":"Rajan","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib143","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/blood-2003-12-4126","article-title":"Anti-CD40L: Biology and therapy in ITP","volume":"103","author":"Schwartz","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib144","doi-asserted-by":"crossref","first-page":"364","DOI":"10.7326\/0003-4819-132-5-200003070-00005","article-title":"Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer","volume":"132","author":"Vadhan-Raj","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib145","first-page":"3118","article-title":"Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer","volume":"89","author":"Basser","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib146","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(96)04471-6","article-title":"Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer","volume":"348","author":"Basser","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib147","first-page":"476","article-title":"Long-term dosing of AMG 531 in thrombocytopenic patients with immune thrombocytopenic purpura: 48-week update","volume":"108","author":"Kuter","year":"2006","journal-title":"ASH Annual Meeting Abstracts"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib148","doi-asserted-by":"crossref","unstructured":"McHutchison JG, Afdhal N, Shiffman ML, Gordon S, Mills P, Sigal S, et al: Efficacy and safety of eltrombopag, an oral platelet growth factor, in subjects with HCV associated thrombocytopenia: Preliminary results from a phase II multicenter, randomised, placebo controlled, double-blind, dose-ranging study. Proceeding of the Annual Meeting of the American Association for the Study of Liver Diseases, 2006 (abstr LB3)","DOI":"10.1016\/S0168-8278(06)80746-4"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib149","first-page":"475","article-title":"Analysis of bleeding in patients with immune thrombocytopenic purpura (ITP): A randomized, double-blind, placebo-controlled trial of eltrombopag, an oral platelet growth factor","volume":"108","author":"Bussel","year":"2006","journal-title":"ASH Annual Meeting Abstracts"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib150","unstructured":"Bussel JB, Provan A, Shamsi T, Cheng G, Kovaleva L, Stone N, et al: Eltrombopag raises platelet count and reduces bleeding compared with placebo during short-term treatment in chronic idiopathic thrombocytopenic purpura: a phase III study. 12th Congress of the European Hematology Association, Vienna, Austria, June 7-10, 2007 (abstr 0390)"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib151","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood-2001-12-0171","article-title":"High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia","volume":"101","author":"Huhn","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2007.11.004_bib152","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0168-8278(95)80027-1","article-title":"Hepatitis C virus infection and autoimmune thrombocytopenic purpura","volume":"23","author":"Pawlotsky","year":"1995","journal-title":"J Hepatol"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196307001618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196307001618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:18:45Z","timestamp":1758521925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196307001618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":152,"alternative-id":["S0037196307001618"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2007.11.004","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Other Immune Thrombocytopenias","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2007.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}